Keyword: Biomanufacturing


Antheia and Olon Continue Biomanufacturing Partnership

14.03.2024 -

US biotech company Antheia and Olon, an Italian producer of active pharmaceutical ingredients (APIs), have announced the continuation of their ongoing partnership to...


Large-Scale Production Announced by Epsilogen and Lonza for Ovarian Cancer Treatment

05.03.2024 -

Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out...


AGC Biologics Completes Expansion at Milan Site

15.08.2023 -

AGC Biologics, a biopharma CDMO, has completed the expansion of its manufacturing capacity at the company’s Cell & Gene Center of Excellence in Milan, Italy.


Moderna to Build New Plant in Massachusetts

06.06.2023 -

After building up manufacturing footholds outside the US, including in Australia, Kenya, South Korea, Canada and the UK, vaccine specialist Moderna is planning to build a...


Sandoz in Biosimilars Pact with Just – Evotec Biologics

12.05.2023 -

As Novartis moves toward shedding generics subsidiary Sandoz, which it touts as a global leader in off-patent generic and biosimilar drugs, Sandoz has agreed a multi-year...


Cytiva Boosts Biomanufacturing with Cevec Buy

11.10.2022 -

US life sciences company Cytiva has acquired Germany’s Cevec Pharmaceuticals, a move Cytiva said would further strengthen its leading position in biomanufacturing...

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...


DSM Announces License Agreement with Amgen

16.01.2013 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a non-exclusive license agreement with Amgen for...